It is born – EU Parliament has approved the AI Act The EU is now equipped with a brand-new regulation for the use of AI. Here are the top 3 insights: The EU has adopted a new regulation for the use of AI, intended to protect the fundamental rights of human beings and promote innovation […]
It is born – EU Parliament has approved the AI Act Read More »
With effect of January 2024, Swissmedic has started with a reorganisation in order to distinct more clear intern responsibilities regarding market surveillance and medical devices. The new department Medical Device Surveillance is responsible for safety of clinical trials, materiovigilance and market monitoring of medical devices. See more infos on Swissmedic website.
The Benefits of Integrating an Information Security Management System to Medical Device Manufacturers Medical device manufacturers face unique challenges when it comes to ensuring the security and privacy of sensitive information such as clinical data or intellectual property of design development. With the increasing prevalence of cyber threats and the need to comply with
The Benefits of Integrating an ISMS to Medical Device Manufacturers Read More »
Understanding EUDAMED – A Key Resource for Medical Device Registration in the EU In the vast landscape of medical devices, one may wonder how regulators manage the enormous amount of information related to manufacturers, product details, safety reports, and clinical trials. The answer, for those operating in the European Union (EU), is a robust, secure
Medical Device Authorized Representative: What is an Authorized Representative: An authorized representative in the medical device industry refers to a legal entity or an individual that acts on behalf of a manufacturer in dealing with regulatory authorities. Their role is to facilitate the manufacturer’s compliance with legislation in the country or region where the
What is an Authorized Representative Read More »
Swissmedic has performed inspections at class 1 manufacturers within Switzerland. The result is impressive, but not surprising due to our experience as Authorised Representative in EU, Switzerland and UK. During our onboarding process EUMEDIQ, we check not only completeness of Technical Documentation of our customer, we also do a plausibility check in order to estimate
Swissmedic has performed inspections at class 1 manufacturers Read More »
In December 2022, the European Commission published the new directive (EU) 2022/2555 on measures for a common level of cybersecurity across the Union. This led to the amendment of the regulation (EU) 910/2014 on electronic identification and trust services for electronic transactions in the internal market (also known as eIDAS regulation) and repeals the NIS
Cybersecurity for Medical Device Manufacturers in EU Read More »
BREAKING NEWS – EUMEDIQ Ltd. has opened its office in London! EUMEDIQ is now providing UK, EU and Swiss Authorised Representative Services next to Consulting (MDR, IVDR, GDPR and ISO 27001 and ISO 13485) and Auditing Services. Further benefits: More wins with maximum efficiency Your qualified partner to reach your target markets High degree of automation and
BREAKING NEWS – EUMEDIQ Ltd. has opened its office in London! Read More »
Medical device startups are mainly combining latest technologies (i.e., interconnectivity of medical devices, software and machine learning diagnosis with the help of Big Data). In doing so they demand highly skilled resources in each field of it. EUMEDIQ is often asked by startups for support in regulatory consulting during design & development stages. The experience
Why regulatory strategy is essential for startup managers Read More »
One of the big changes in EU MDR 2017/745 in contrast to the MDD are the clear requirements on the handling of substances which are carcinogenic, mutagenic or toxic to reproduction (‘CMR’). Fortunately, manufacturers are not meant to define by themselves which substances are considered CMR. REGULATION (EC) No 1272/2008, Annex VI, part 3 provides